Helicobacter pylori Eradication after Endoscopic Resection of Gastric Epithelial Neoplasms
- Author:
Ji Min CHOI
1
;
Sang Gyun KIM
Author Information
- Publication Type:Review
- Keywords: Helicobacter pylori; Neoplasms, second primary; Stomach neoplasms; Therapeutics
- MeSH: Gastritis, Atrophic; Helicobacter pylori; Helicobacter; Humans; Incidence; Metaplasia; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Prospective Studies; Retrospective Studies; Stomach Neoplasms
- From:The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019;19(4):220-224
- CountryRepublic of Korea
- Language:Korean
- Abstract: Endoscopic submucosal dissection is widely accepted as standard treatment for early gastric cancer; however, long-term management of metachronous gastric cancer after endoscopic resection is an important issue that is gaining much attention. Several prospective and retrospective studies have reported that Helicobacter pylori (H. pylori) eradication can reduce the risk of metachronous gastric cancer after endoscopic resection. Although there is lack of sufficient data regarding this subject, a few studies have reported histologically proven improvement in atrophic gastritis and intestinal metaplasia following H. pylori eradication in patients undergoing endoscopic resection. Therefore, treatment for H. pylori eradication should be considered in this patient population to reduce the incidence of metachronous gastric cancer and improve long-term outcomes.(
